It has been demonstrated that patients experiencing mild cognitive impairment and dementia stages of AD have increased blood and CSF NfL levels [35], from these results it has been previously proposed that NfL may be able to help predict the progression of AD dementia in patients [33, 34]. The gene discussed is NEFL; the disease is Alzheimer disease.